
Italy · Medical devices startup
InnovHeart is an Italian medical device company based in Milan, specializing in the development of Transcatheter Mitral Valve Replacement (TMVR) systems.
Funding reportedLast round: Series C
Follow InnovHeart and see its new rounds in your feed.Start following
InnovHeart is an Italian medical device company based in Milan, specializing in the development of Transcatheter Mitral Valve Replacement (TMVR) systems.
Founded in 2015, the company focuses on providing safe and effective treatment options for patients with moderate to severe mitral regurgitation. InnovHeart aims to replace malfunctioning mitral valves using a minimally invasive approach, reducing the risks associated with traditional open-heart surgery. The company's flagship product, the Saturn TMVR System, is designed for optimal anatomical compatibility and features a low-profile prosthesis that ensures unimpeded blood flow. The Saturn system is currently in clinical trials, with a focus on validating its safety and efficacy. InnovHeart serves healthcare providers, including cardiologists and cardiothoracic surgeons, and is expanding its market presence in Europe, the United States, and Asia through strategic partnerships and funding initiatives. The company is dedicated to improving the quality of life for patients with heart valve dysfunction.
Funding, as reported
What they build
Known for
health caremanufacturingmitral regurgitation treatmenttranscatheter interventionmedical equipment manufacturingsaturn transcatheter mitral valvecardiologypercutaneous heart valvetmvrmedical device innovationheart valve therapypercutaneous mitral valveclinical researchhospital & health careheart valve interventionminimally invasive valve replacement
Built with from their website
Google Tag ManagerWordPress.orgYouTubeCloudFlareViewport MetaMimecastWP EngineEmbedPlusGoogle Cloud HostingCloudFlare CDN
Priority HintsGoogle Font APIMicrosoft ExchangeFitVids.JSCookiebotMySQLPrimeNGMicrosoft 365 Apps & Services
Add your raise, your deck and your story, and put InnovHeart in front of investors. Or tell us what we have wrong.